Borosil Scientific Approves ₹70 Cr Capacity Expansion, Q2 Results Announced
Borosil Scientific will invest up to ₹70 crore to set up a Borosilicate 3.3 glass tubing furnace at its Bharuch plant, aiming for commercial production by March 31, 2028. The company also announced its Q2 financial results, reporting revenue from operations of ₹10,419.39 lakh (standalone) for the quarter ended September 30, 2026.
The approval of a new glass tubing furnace with a significant capital expenditure of ₹70 crores and a clear timeline for commencement of commercial production by March 31, 2028, is a material development that is expected to have a substantial impact on the company's future operations and financial performance.
The announcement includes a significant capacity expansion project with a substantial investment, indicating future growth prospects. The financial results, while needing detailed analysis, show continued revenue generation. The overall sentiment is positive due to the strategic expansion initiative.
Borosil Scientific Limited announced the outcome of its Board Meeting held on October 28, 2026. The board approved the unaudited financial results for the quarter and half-year ended September 30, 2026, both on standalone and consolidated bases. Additionally, the company approved a significant capacity addition by setting up a Borosilicate 3.3 glass tubing furnace at its Bharuch plant. This new furnace will have an installed production capacity of approximately 20 Metric Tonnes per day. The company anticipates commercial production to commence by March 31, 2028, with an estimated capital expenditure of up to ₹70 crores. The rationale behind this expansion includes backward integration, reducing dependence on imported tubing, improving supply chain reliability, and optimizing manufacturing costs for glassware products. The financing for this project will be through internal accruals and/or borrowings. The company also mentioned that it would apply for subsidy benefits under the Viksit Gujarat Industrial Policy 2026.
The financial results for the quarter ended September 30, 2026, showed revenue from operations of ₹10,419.39 lakhs (standalone) and ₹11,496.37 lakhs (consolidated). Profit Before Tax (PBT) for the quarter stood at ₹893.10 lakhs (standalone) and ₹767.10 lakhs (consolidated). For the half-year ended September 30, 2026, revenue from operations was ₹20,409.07 lakhs (standalone) and ₹22,171.60 lakhs (consolidated), with PBT at ₹1,824.21 lakhs (standalone) and ₹1,365.17 lakhs (consolidated).
What to do with a filing like this
Borosil Scientific Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Borosil Scientific Limited. Read the original for the full detail.